DK22389D0 - Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma - Google Patents

Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma

Info

Publication number
DK22389D0
DK22389D0 DK022389A DK22389A DK22389D0 DK 22389 D0 DK22389 D0 DK 22389D0 DK 022389 A DK022389 A DK 022389A DK 22389 A DK22389 A DK 22389A DK 22389 D0 DK22389 D0 DK 22389D0
Authority
DK
Denmark
Prior art keywords
mycoplasma
organisms
medicine
micro
namely
Prior art date
Application number
DK022389A
Other languages
English (en)
Other versions
DK22389A (da
Inventor
Daryl H Faulds
Mimi Vishoot
Original Assignee
Ml Technology Ventures
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ml Technology Ventures filed Critical Ml Technology Ventures
Publication of DK22389D0 publication Critical patent/DK22389D0/da
Publication of DK22389A publication Critical patent/DK22389A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/21—Endodeoxyribonucleases producing 5'-phosphomonoesters (3.1.21)
    • C12Y301/21001—Deoxyribonuclease I (3.1.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Fodder In General (AREA)
DK022389A 1988-01-20 1989-01-19 Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma DK22389A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/146,256 US4985243A (en) 1988-01-20 1988-01-20 Composition and method for protecting against diseases caused by microorganisms

Publications (2)

Publication Number Publication Date
DK22389D0 true DK22389D0 (da) 1989-01-19
DK22389A DK22389A (da) 1989-07-21

Family

ID=22516535

Family Applications (1)

Application Number Title Priority Date Filing Date
DK022389A DK22389A (da) 1988-01-20 1989-01-19 Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma

Country Status (11)

Country Link
US (1) US4985243A (da)
EP (1) EP0325191B1 (da)
JP (1) JPH0768142B2 (da)
AT (1) ATE127693T1 (da)
DE (1) DE68924183T2 (da)
DK (1) DK22389A (da)
ES (1) ES2078900T3 (da)
GR (1) GR3017427T3 (da)
IE (1) IE890141L (da)
PT (1) PT89488A (da)
ZA (1) ZA89447B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240706A (en) * 1989-04-07 1993-08-31 Ml Technology Ventures, L.P. Intranasal administration of Mycoplasma hyopneumoniae antigen
ATE160699T1 (de) * 1990-05-29 1997-12-15 American Cyanamid Co Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung
US6113916A (en) * 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
USRE39494E1 (en) * 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
PT839050E (pt) * 1992-09-28 2004-11-30 Wyeth Corp Metodo de melhorar respostas imunes mediadas por celulas
US5498527A (en) * 1994-02-18 1996-03-12 Ube Industries, Ltd. Phosphorylcholine-containing glyceroglycolipid
US9248166B2 (en) 2003-07-14 2016-02-02 Cls Therapeutics Limited Method for treating oncological diseases
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
EP1666055A4 (en) * 2003-07-14 2010-02-10 Viktor Veniaminovich Tets METHOD OF TREATMENT OF ONCOLOGICAL, INFECTIOUS, AND SOMATIC DISEASES, METHODS OF MONITORING THE EFFICACY OF TREATMENT, AGENTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
EP1880733A4 (en) 2005-04-25 2009-08-12 Genkin Dmitry Dmitrievich Method for increasing longevity of a human being and animals
AU2006289626A1 (en) * 2005-09-09 2007-03-15 Universitat Zurich Antigens for vaccination against and detection of Mycoplasma suis
KR20090087095A (ko) 2006-11-28 2009-08-14 드미트리 드미트리에비치 겐킨 조직의 세포외공간에서 증가된 데옥시리보핵산 함량과 관련된 인간 질병을 치료하는 방법 및 이 방법을 수행하기 위한 약학 제제
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
CN104784465B (zh) * 2015-04-14 2017-11-03 中国农业科学院兰州畜牧与兽药研究所 一种用于防治猪气喘病的中药组合物及其制备方法和应用
RU2726131C2 (ru) 2015-05-22 2020-07-09 Дмитрий Дмитриевич Генкин Внеклеточная днк в качестве терапевтической мишени при нейродегенерации
US11905522B2 (en) 2018-01-16 2024-02-20 Cls Therapeutics Limited Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity
CN109234253B (zh) * 2018-09-19 2021-02-19 中国农业大学 Mhp非特异性核酸酶及其编码基因与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485721A (en) * 1968-04-24 1969-12-23 Merck & Co Inc Process for growing mycoplasma pneumonial organisms
US4123427A (en) * 1976-07-27 1978-10-31 Daniel Thomas M Method for the purification of mycobacterial protein antigens and resulting product
FR2565825B1 (fr) * 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
US4666851A (en) * 1985-04-25 1987-05-19 Lee Sin H Specific mycoplasma membrane antigen and antibody and their clinical applications

Also Published As

Publication number Publication date
EP0325191A3 (en) 1990-04-04
ZA89447B (en) 1989-10-25
DE68924183T2 (de) 1996-03-21
JPH0768142B2 (ja) 1995-07-26
PT89488A (pt) 1989-10-04
EP0325191A2 (en) 1989-07-26
ES2078900T3 (es) 1996-01-01
JPH02711A (ja) 1990-01-05
GR3017427T3 (en) 1995-12-31
ATE127693T1 (de) 1995-09-15
DK22389A (da) 1989-07-21
US4985243A (en) 1991-01-15
IE890141L (en) 1989-07-20
EP0325191B1 (en) 1995-09-13
DE68924183D1 (de) 1995-10-19

Similar Documents

Publication Publication Date Title
DK22389A (da) Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma
FI960977A0 (fi) Bakteeriperäiset eksportoidut proteiinit ja niihin perustuvat asellulaariset rokotteet
DK0382173T3 (da) Substans PF 1022, fremgangsmåde til fremstilling heraf og anthelmintisk præparat indeholdende denne
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
IT8024658A0 (it) Placca per giunzioni di porzioni d'osso separate da frattura.
NO965590D0 (no) Polynukleotidvaksine for papillomavirus
ATE197765T1 (de) Zusammensetzung enthaltend ein antigen exprimierendes rekombinantes virus und ein immunstimulierendes molekül exprimierendes rekombinantes virus
DE69536039D1 (de) Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
DK0749321T3 (da) Aktiv immunisering under anvendelse af et sideroforreceptorprotein
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
DK235687D0 (da) Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf
FI952148L (fi) Geenitekninen menetelmä ja isäntä ksylitolin valmistamiseksi
ES487046A1 (es) Procedimiento de preparacion de proteoglicanos membranarios bacterianos purificados
ES2083396T3 (es) Acidos fenilalcan(en)oicos.
EA200100700A1 (ru) Гены и белки и их применение
SE8105079L (sv) Antibiotikum bmg162-af2
AU1681095A (en) Hydrophilic signal oligopeptides and methods of therapeutic use
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
EP0529019A4 (en) Nematode vaccine
DK439082A (da) 4-acylamino-1-aza-adamantan-forbindelser samt fremgangsmaade til fremstilling deraf
IT7819138A0 (it) Procedimento per la coltura di microrganismi.
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
NO170936C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte vinylcefalosporiner
ATE108832T1 (de) Verwendung von monoklonalen antikörpern gegen b2- mikroglobulin.
ATE212839T1 (de) Hämoregulatorische verbindungen

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment